The Value in Health Regional Issues Excellent Article Award was established in 2014 to recognize the best article published in Value in Health Regional Issues from a region, (Asia; Latin America; and Central and Eastern Europe, Western Asia, and Africa). The objective of this award is to promote quality research, originality, and utility in healthcare decisions for articles published in Value in Health Regional Issues.
The award is given to the best article published in Value in Health Regional Issues from each region biennially. The recognized article will represent a major contribution to the field of health economics and outcomes research [including clinical, economic, and patient-reported (health-related quality of life) outcomes] or its use in healthcare decision making. Articles that present original research, development of new methods, health policy analysis, and reviews are considered. Articles such as editorials, commentaries, and letters are excluded from consideration for this award.
A candidate may only be nominated for 1 major ISPOR award in a year.
Value in Health Regional Issues Editors from each region (Asia; Latin America; and Central and Eastern Europe, Western Asia, and Africa) will nominate two-three best articles from the articles that he/she has handled in the two most recently published issues of their region and will generate a list of nominated articles. The Editor-in-Chief of each region will then select the best article from the list. The nominee is then forwarded to the ISPOR Board of Directors for approval. If the article has also been selected as a recipient of an ISPOR Research Excellence Award, and if the Awards Committee feels that this should be avoided, the Value in Health Regional Issues Editor-in-Chief of the region can be instructed to consult the Chairs of the ISPOR Research Excellence Awards Committee before confirming the selection. The corresponding author on the best article is given the Value in Health Regional Issues Excellent Article Award.
Nature of Award:
The award will consist of a plaque presented to the corresponding author of the best article of the region at an ISPOR regional conference (ISPOR Asia Pacific or ISPOR Latin America) or the ISPOR Europe conference depending on the region the article represents. The recipient (corresponding author) of the award will receive a complimentary conference registration, roundtrip air fare (coach), hotel, meal and other travel expenses for two days (based upon current ISPOR travel reimbursement policies).
Value in Health Regional Issues
Excellent Article Award Recipients
2019 (Central and Eastern Europe, Western Asia, and Africa)
Alexandra Beletsi, PharmD, PhD
Servier Hellas Pharmaceuticals EPE, Athens, Greece
For the paper, Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union, Value in Health Regional Issues 2018;16:81-91.
2019 (Latin America)
José Miguel Uribe-Restrepo, MD, MPH
Javeriana University Medical School, in Bogata, Colombia
For the paper, Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia, Value in Health Regional Issues 2017;13:15-19.
Eui-Kyung Lee, PhD
Sungkyunkwan University, South Korea
For the paper, Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea, Value in Health Regional Issues (2017); 12:7-9.
2017 (Latin America)
Ivan Mauricio Muñoz-Galindo, RN, MSc
National Health Risk Management, EPS Salud Total, Bogotá D.C. Colombia
For the paper, Cost-Effectiveness of a Care Program for HIV/AIDS Patients Affiliated with a Health Insurer in Colombia, Comparing Three Health Care Providers Nationwide, Value in Health Regional Issues (2016); 11:1-8.
2017 (Central and Eastern Europe, Western Asia, and Africa)
Aleš Tichopád, PhD
Kantar Health s.r.o., Prague, Czech Republic
For the paper, Cost Burden of Severe Community–Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective Patient Chart Review, Value in Health Regional Issues (2016); 10:53-60.
Following his graduation at the Technical University Munich, Ales Tichopad has been working for several research organization in various roles from Biostatistician, Health Economics Analyst to Managing Director. In 2008 Ales Tichopad co-founded CEEOR, the Central and Eastern European Outcomes Research organization that provided its worldwide customers with Real World Evidence and Market Access Services in the Central and Eastern Europe and on other predominantly emerging markets. Beside his role in CEEOR Ales Tichopad was active in academia, lecturing at Technical University Munich, Czech Technical University Prague and Czech Academy of Science. In 2015, CEEOR was acquired by Kantar Health.
Fei-Li Zhao, PhD, MSc, BPharm
Senior Research Fellow, Centre for Health Economics Research and Evaluation (CHERE), Business School, University of Technology Sydney (UTS), Australia
For the paper, Burden of Disease Studies in the Asia-Paific Region: Are There Enough being Performed to Provide for Evidence-Based Health Policy? (by Zhao, Gao, and Li), Value in Health Regional Issues (2013); 2:152-159.
Fei-Li Zhao, PhD, is a health economist with experiences gained from working in both academia and industry. Her research capacity and interests lie in economic evaluation using trial and real-world data, quality of life research and preference measurement, and health services research in Asia Pacific countries. Dr Zhao regularly undertakes research on behalf of the government and non-government agencies. This includes providing high quality, expert health technology assessment advice and support to the Pharmaceutical Benefits Advisory Committee (PBAC) for national reimbursement decision makings of pharmaceuticals and vaccines in Australia. She has presented nationally and internationally on her research and published series of papers on high-profile journals such as Value in Health, Pharmacoeconomics, PLOS One, Medical Care, Health Quality of Life Outcomes and BMC pregnancy and childbirth.
2016 (Latin America)
Mônica Viegas Andrade, PhD
Associate Professor, Universidad Federal de Minas Gerais, Belo Horizonte, Brazil & Harvard School of Public Health, Boston, MA, USA
For the paper, Societal Preferences for EQ-5D Health States from a Brazilian Population Survey, Value in Health Regional Issues 2013; 2:405-412.
Dr. Andrade is an Associate Professor at the Economics Department at the Federal University of Minas Gerais, Belo Horizonte, Brazil. Dr. Andrade works with applied microeconomics, specifically with health economics and evaluation of social programs. She received her PhD in Economics at the Graduate School of Getulio Vargas Foundation (1996 to 2000), Rio de Janeiro, and won the Award of best PhD dissertation, provided by the Associação Nacional de pós-Graduação em Economia, Haralambus Simonidis in 2000. In 2008-2009, she spent one year as a visiting researcher at Pompeu Fabra University, Center for Health Economics. At the Federal University of Minas Gerais, Monica is the leader of Health Economics Research Group, Grupo de Estudos em Economia da Saude e Criminalidade. The research group has carried out important investigations, including the estimation of social preferences for EQ-5D health states for Brazil. Monica was also the Dean of the Graduate Program of Economics during the period of 2003-2008. Monica is currently spending one year as a Takemi Fellow at Harvard School of Public Health, Global Health and Population Department. Monica is also a Researcher 1D of the National Council of Research (CNPQ) in Brazil and Member of the Committee (Economics) of the National Council of Research in Brazil.
2015 (Central and Eastern Europe, Western Asia, and Africa)
Rok Hren, PhD, MSc
President, ISPOR Slovenia Chapter, Assistant Professor, University of Ljubljana, Managing Director of Carso, a Member of Salus Group PLC (SALR. SI), Ljubljana, Slovenia
For the paper, “Impact of the Pharma-Economic Act on Diffusion of Innovation and Reduction of Costs in the Hungarian Prescription Drug Market (2007–2010)”, Value in Health Regional Issues 2013; 2:290-299.
Rok Hren, PhD, has more than 15 years of commercial experience in pharmaceutical industry, with more than 10 years on a board level in both line management, which has included full P&L responsibility for operations in Slovenia and Romania, and regional leadership functions in Central and Eastern Europe. He regularly presents on the topic of pharmaceutical economics and policies at conferences in Europe and is well experienced in health care media business. Currently, he holds the position of a Managing Director of Carso, a Member of Salus Group PLC (SALR.SI). He received his PhD in Physiology and Biophysics from Dalhousie University, Canada and MSc in International Health Policy (Health Economics) with distinction from London School of Economics and Political Science, UK. He is also an Assistant Professor at the University of Ljubljana and a President of ISPOR Slovenia Regional Chapter. In total, his publications gathered 240/341citations (excluding self-citations) in WoS/Scopus (as of September 16, 2015).
Contribute to Value in Health Regional Issues
- Submit a manuscript/revision
- Become a peer reviewer
- Check manuscript status